Actively Recruiting
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
Led by Centre Hospitalier Universitaire de Nice · Updated on 2025-03-19
20
Participants Needed
1
Research Sites
67 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.
CONDITIONS
Official Title
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Platelet counts and clotting factors within standard levels
- Diagnosed with severe dry keratoconjunctivitis by an ophthalmologist
You will not qualify if you...
- Significant fibrosis of the conjunctival portion of the lacrimal gland
- Complete stenosis of both lacrimal meatus in the treated eye
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Nice
Nice, Site Principal Investigator, France, 06000
Actively Recruiting
Research Team
D
Doctor Jean Philippe GROSSE, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here